Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis. [electronic resource]
Producer: 20180521ISSN:- 1941-7632
- Aged
- Angioplasty, Balloon -- adverse effects
- Antioxidants -- administration & dosage
- Atherosclerosis -- blood
- Computed Tomography Angiography
- Double-Blind Method
- Female
- Glomerular Filtration Rate -- drug effects
- Humans
- Hypoxia -- blood
- Infusions, Intravenous
- Kidney -- drug effects
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Mitochondria -- drug effects
- Multidetector Computed Tomography
- Oligopeptides -- administration & dosage
- Oxidative Stress -- drug effects
- Perfusion Imaging -- methods
- Pilot Projects
- Recovery of Function
- Renal Artery Obstruction -- blood
- Renal Circulation -- drug effects
- Reperfusion Injury -- blood
- Risk Factors
- Stents
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.